semaglutide muscle loss is one of the most common concerns raised about GLP-1 medications, and it deserves a more precise answer than it usually gets. A recently published mouse study added ketone supplementation Semaglutides may not shrink muscles

Endogenous insulin secretion was evaluated by the measurement of C-peptide (CPR) and C-peptide index (CPI) [15], and the biochemical parameters, including plasma glucose, were measured in blood samples collected after an overnight fast

A 2016 comparative study published in Nature Scientific Reports directly compared copper compounds and found GHK-Cu non-cytotoxic across all tested concentrations up to 5,800 micromolar over 72 hours

Blood 115, 27692776 (2010)

Find Out More Diversity Matters Wolters Kluwer continuously strives for an inclusive company culture in which we attract, develop, and retain high-performing, productive, engaged, and diverse talent to deliver on our strategy

So, even before looking at drug-specific fetal concerns, the treatment purpose alone makes semaglutide a poor fit for routine pregnancy use